Seminars in Hematology
Volume 46, Issue 4 , Pages 339-350 , October 2009

Pathogenesis and Management of Iron Deficiency Anemia: Emerging Role of Celiac Disease, Helicobacter pylori, and Autoimmune Gastritis

  • Chaim Hershko

      Affiliations

    • Department of Hematology, Shaare Zedek Medical Center and Hebrew University of Jerusalem, Israel
    • Corresponding Author InformationAddress correspondence to Chaim Hershko, MD, Department of Hematology, Shaare Zedek Medical Center, PO Box 3235, Jerusalem, Israel
    • ,
  • Barry Skikne

      Affiliations

    • Division of Hematology/Oncology, Kansas University Medical Center, Kansas City, KS

References 

  1. Haas JD, Brownlie T. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001;131(Suppl 2):676S–688S
  2. Halterman JS, Kaczorowski JM, Aligne CA, Auinger P, Szilagyi PG. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics. 2001;107:1381–1386
  3. Algarin C, Peirano P, Garrido M, Pizarro F, Lozoff B. Iron deficiency anemia in infancy: long-lasting effects on auditory and visual system functioning. Pediatr Res. 2003;53:217–223
  4. Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, et al. Iron supplementation for unexplained fatigue in non-anemic women: double blind randomized placebo controlled trial. BMJ. 2003;326:1124–1127
  5. Willoughby JMT, Laitner SM. Audit of the investigation of iron deficiency anemia in a district general hospital, with sample guidelines for future practice. Postgrad Med J. 2000;76:218–222
  6. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (ret he) and assessment of iron-deficient states. Clin Lab Haematol. 2006;28:303–308
  7. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood. 2000;96:823–833
  8. Macdougall IC, Horl WH, Jacobs C, Valderrabano F, Parrondo I, Thompson K, et al. European Best Practice Guidelines 6-8: assessing and optimizing iron stores. Nephrol Dial Transplant. 2000;15:20–32
  9. Fleming DJ, Jacques PF, Dallal GE, Tucker KL, Wilson PWF, Wood RJ. Dietary determinants of iron stores in a free-living elderly population (The Framingham Heart Study). Am J Clin Nutr. 1998;67:722–733
  10. Cook JD, Dassenko SA, Whittaker P. Calcium supplementation: effect on iron absorption. Am J Clin Nutr. 1991;53:106–111
  11. Hallberg L, Rossander-Hulten L, Brune M, Gleerup A. Calcium and iron absorption: mechanism of action and nutritional importance. Eur J Clin Nutr. 1992;46:317–327
  12. Hallberg L, Brune M, Erlandsson M, Snadberg AS, Rossander-Hulten L. Calcium: effect of different amounts on nonheme– and heme-iron absorption in humans. Am J Clin Nutr. 1991;53:112–119
  13. Roughead ZK, Zito CA, Hunt JR. Initial uptake and absorption of nonheme iron and absorption of heme iron in humans are unaffected by the addition of calcium as cheese to a meal with high iron bioavailability. Am J Clin Nutr. 2002;76:419–425
  14. Beard JL. Iron requirements in adolescent females. Am Soc Nutr Sci. 2000;440S–442S
  15. Hallberg L. Iron requirements, iron balance and iron deficiency in menstruating and pregnant women. In:  Hallberg L,  Asp NG editor. Iron Nutrition in Health and Disease. John Libbey; 1996;p. 165–182
  16. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss—a population study (Variation at different ages and attempts to define normality). Acta Obstet Gynecol Scand. 1966;45:320–351
  17. Bothwell TH, Charlton RW. Assessment of the iron nutritional status of a population. Prog Clin Biol Res. 1981;77:311–321
  18. Andrade A, Wildemeersch D. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS. Contraception. 2009;79:134–138
  19. Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr. 2003;78:45–153
  20. Ahluwalia N, Skikne BS, Savin V, Chonko A. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. Am J Kidney Dis. 1997;30:532–541
  21. Skikne BS, Ahluwalia N, Fergusson B, Chonko A, Cook JD. Effects of erythropoietin therapy on iron absorption in chronic renal failure. J Lab Clin Med. 2000;135:452–458
  22. Raje D, Mukhtar H, Oshowo A, Ingham Clark C, Chir M. What proportion of patients referred to secondary care with iron deficiency anemia have colon cancer?. Dis Colon Rectum. 2007;50:1211–1214
  23. Acher PL, Al-Mishlab T, Rahman M, Bates T. Iron deficiency anemia and delay in the diagnosis of colorectal cancer. Colorectal Dis. 2003;5:145–148
  24. Dickey W, Hughes D. Prevalence of celiac disease and its endoscopic markers among patients having routine upper gastrointestinal endoscopy. Am J Gastr. 1999;94:2182–2186
  25. Choe YH, Kwon YS, Jung MK, et al. Helicobacter pylori-associated iron-deficiency anemia in adolescent female athletes. J Pediatrics. 2001;139:100–104
  26. Annibale B, Marignani M, Monarca B, et al. Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann Intern Med. 1999;131:668–672
  27. Annibale B, Capurso G, Chistolini A, et al. Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms. Am J Med. 2001;111:439–445
  28. Dickey W, Kenny BD, McMillan SA, Porter KG, McConnell JB. Gastric as well as duodenal biopsies may be useful in the investigation of iron deficiency anaemia. Scand J Gastroenterol. 1997;32:469–472
  29. Hershko C, Ronson A, Souroujon M, Cabantchik ZI, Patz J. Mechanisms of iron regulation and of iron deficiency. Haematologica. 2007;1:1–9
  30. Halfdanarson TR, Litzow MR, Murray JA. Hematologic manifestations of celiac disease. Blood. 2007;109:412–421
  31. Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR. The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol. 1999;94:691–696
  32. Corazza GR, Valentini RA, Andreani ML, et al. Subclinical coeliac disease is a frequent cause of iron-deficiency anaemia. Scand J Gastroenterol. 1995;30:153–156
  33. Carroccio A, Iannitto E, Cavataio F, et al. Sideropenic anemia and celiac disease: one study, two points of view. Dig Dis Sci. 1998;43:673–678
  34. Howard MR, Turnbull AJ, Morley P, Hollier P, Webb R, Clarke A. A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency. J Clin Pathol. 2002;55:754–757
  35. Mandal AK, Mehdi I, Munshi SK, Lo TC. Value of routine duodenal biopsy in diagnosing celiac disease in patients with iron deficiency anaemia. Postgrad Med J. 2004;80:475–477
  36. Chorzelski TP, Beutner EH, Sulej J, et al. IgA anti-endomysium antibody (A new immunological marker of dermatitis herpetiformis and coeliac disease). Br J Dermatol. 1984;111:395–402
  37. Faber K. Achylia gastrica mit Anamie. Medizinishe Klinik. 1909;5:1310–1325
  38. Wintrobe MM, Beebe RT. Idiopathic hypochromic anemia. Medicine. 1933;12:187–243
  39. Hershko C, Hoffbrand AV, Keret D, Souroujon M, Maschler I, Monselise Y, et al. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica. 2005;90:585–595
  40. Celada A, Rudolf H, Herreros V, Donath A. Inorganic iron absorption in subjects with iron deficiency anemia, achylia gastrica and alcoholic cirrhosis using a whole-body counter. Acta Haematol. 1978;60:182–192
  41. Cook JD, Brown GM, Valberg LS. The effect of achylia gastrica on iron absorption. J Clin Invest. 1964;43:1185–1191
  42. Schade SG, Cohen RJ, Conrad ME. The effect of hydrochloric acid on iron absorption. N Engl J Med. 1968;279:621–624
  43. Bezwoda W, Charlton R, Bothwell T, et al. The importance of gastric hydrochloric acid in the absorption of nonheme food iron. J Lab Clin Med. 1978;92:108–116
  44. Milman N, Rosenstock S, Andersen L, et al. Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiologic survey comprising 2794 Danish adults. Gastroenterology. 1998;115:268–274
  45. Baggett HC, Parkinson AJ, Muth PT, Gold BD, Gessner BD. Endemic iron deficiency associated with Helicobacter pylori infection among school-aged children in Alaska. Pediatrics. 2006;117:e396–e404
  46. Parkinson AJ, Gold BD, Bulkow L, Wainwright RB, Swaminathan B, Khanna B, et al. High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol. 2000;7:885–888
  47. Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol. 2006;163:127–134
  48. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175–1186
  49. Dufour C, Brisigotti M, Fabretti G, Luxardo P, Mori PG, Barabino A. Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr. 1993;17:225–227
  50. Choe YH, Kim SK, Son BK, et al. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter. 1999;4:135–139
  51. Choe YH, Lee JE, Kim SK. Effect of Helicobacter pylori eradication on sideropenic refractory anaemia in adolescent girls with Helicobacter pylori infection. Acta Paediatr. 2000;89:154–157
  52. Hershko C, Ianculovich M, Souroujon M. A hematologist's view of unexplained iron deficiency anemia in males: impact of Helicobacter pylori eradication. Blood Cells Mol Dis. 2007;38:45–53
  53. Beutler E. Commentary: hepcidin mimetics from microorganisms? (A possible explanation for the effect of Helicobacter pylori on iron homeostasis). Blood Cells Mol Dis. 2007;38:54–56
  54. Du X, She E, Gelbart T. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008;320:1088–1092
  55. Ciacci C, Sabbatini F, Cavallaro R, Castiglione F, Di Bella S, Iovino P, et al. Helicobacter pylori impairs iron absorption in infected individuals. Dig Liver Dis. 2004;36:455–460
  56. Annibale B, Capurso G, Lahner E, et al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut. 2003;52:496–501
  57. Hershko C, Ronson A, Souroujon M, et al. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006;107:1673–1679
  58. Stopeck A. Links between Helicobacter pylori infection, cobalamin deficiency, and pernicious anemia. Arch Intern Med. 2000;160:1229–1230
  59. Appelmelk BJ, Simoons-Smit I, Negrini R, et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun. 1996;64:2031–2040
  60. Negrini R, Savio A, Appelmelk BJ. Autoantibodies to gastric mucosa in Helicobacter pylori infection. Helicobacter. 1997;1:S13–S16
  61. Ma JY, Borch K, Sjostrand SE, et al. Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol. 1994;29:961–965
  62. Claeys D, Faller G, Appelmelk BJ, et al. The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology. 1998;115:340–347
  63. Negrini R, Savio A, Poiesi C, et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology. 1996;111:655–665
  64. Jassel SV, Ardill JE, Fillmore D, et al. The rise in circulating gastrin with age is due to increases in gastric autoimmunity and Helicobacter pylori infection. Q J Med. 1999;92:373–377
  65. Appelmelk BJ, Negrini R, Moran AP, Kuipers EJ. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol. 1997;5:70–73
  66. Rad R, Schmid RM, Prinz C. Helicobacter pylori, iron deficiency, and gastric autoimmunity. Blood. 2006;107:4969–4970
  67. Annibale B, Di Giulio E, Caruana P, et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment Pharm Ther. 2002;16:1723–1731
  68. Kaptan K, Beyan C, Ural AU, et al. Helicobacter pylori—is it a novel causative agent in vitamin B12 deficiency?. Arch Intern Med. 2000;160:1349–1353
  69. Haruma K, Mihara M, Okamoto E, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h pH monitoring. Aliment Pharm Ther. 1999;13:155–162
  70. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98:974–983
  71. Mera R, Fontham ET, Bravo LE, et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut. 2005;54:1536–1540
  72. Bourke B, Ceponis P, Chiba N, et al. Canadian Helicobacter Study Group Consensus Conference: update on the approach to Helicobacter pylori infection in children and adolescents—an evidence-based evaluation. Can J Gastroenterol. 2005;19:399–408
  73. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772–781
  74. McColl KEL, Murray LS, Gillen D, et al. Randomized trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia. Br Med J. 2002;324:999–1002
  75. Brise H, Hallberg L. Absorbability of different iron compounds. Acta Med Scand. 1962;17(Suppl):23–37
  76. Tarng DC, Huang TP, Chen TW, Yang WC. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int Soc Nephrol. 1995;55(Suppl 69):S107–S118
  77. Fishbane S, Ungureanu VD, Maesaka JK, Kaupke CJ, Lim V, Wish J. The safety of intravenous iron dextan in hemodialysis patients. Am J Kidney Dis. 1996;28:529–534
  78. Michael B, Coyne DW, Fishbane S, Folker V, Lynn R, Nissenson AR, et al. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int. 2002;61:1830–1839
  79. Miller HJ, Hu J, Valentine JK, Gable PS. Efficacy and tolerability of intravenous ferric gluconate in the treatment of iron deficiency anemia in patients without kidney disease. Arch Intern Med. 2007;167:1327–1328
  80. Charytan C, Schwenk MH, Al-Saloum MM, Spinowitz BS. Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products. Nephron Clin Pract. 2004;96:C63–C66
  81. Besarab A. More than a decade of experience and still no consensus: controversies in iron therapy. Clin J Am Soc Nephrol. 2006;S1–S3
  82. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: update 2006. Am J Kidney Dis. 2006;4(Suppl):S1–S145
  83. Drueke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ, et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation. 2002;106:2212–2217
  84. Reis KA, Guz G, Ozdemir H, Erten Y, Atalay V, Vicik Z, et al. Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease. Int Heart J. 2005;46:255–264
  85. Van Wyck D, Anderson J, Johnson K. Labile iron in parenteral iron formulations: a quantitative and comparative study. Nephrol Dial Transplant. 2004;19:561–565
  86. Rooyakkers TM, Stroes ES, Kooistra MP, van Faassen EE, Hider RC, Rabelink TJ, et al. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest. 2002;32(Suppl 1):9–16
  87. Zager RA. Parenteral iron compounds potent oxidants but mainstays of anemia management in chronic renal disease. Am Soc Nephrol. 2006;S24–S31
  88. Tagboto S, Cropper L, Turner J, Pugh-Clarke K. The efficacy of a single dose of intravenous ferric carboxymaltose (Ferinject) on anaemia in a pre-dialysis population of chronic kidney disease patients. J Renal Care. 2009;35:18–23
  89. Auerbach M, Goodnough LT, Picard D, Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion. 2008;48:988–1000
  90. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006;47(Suppl 3):S11–S145
  91. Coyne DW. A comprehensive vision for intravenous iron therapy. Am J Kidney Dis. 2008;52:S14–S20
  92. Cook JD, Carriaga M, Kahn SG, Schalch W, Skikne BS. Gastric delivery system for iron supplementation. Lancet. 1990;335:1136–1139

PII: S0037-1963(09)00099-7

doi: 10.1053/j.seminhematol.2009.06.002

Seminars in Hematology
Volume 46, Issue 4 , Pages 339-350 , October 2009

Article Tools